Description
The Beta-2-Glycoprotein I IgG Antibody Serum test detects IgG antibodies targeting Beta-2-Glycoprotein I, a key protein in blood clotting. This test is crucial in diagnosing antiphospholipid syndrome (APS), an autoimmune disorder associated with increased risk of blood clots, recurrent miscarriages, and other pregnancy complications. The presence of these IgG antibodies is considered more specific for APS than IgA or IgM antibodies. Positive results can indicate a higher risk of thrombotic events or pregnancy-related issues. This test is often performed in conjunction with other antiphospholipid antibody tests for a comprehensive evaluation. The results guide important clinical decisions, such as the need for anticoagulation therapy or specialized management during pregnancy. Regular monitoring with this test can help in assessing the effectiveness of treatment and managing long-term risks associated with APS.
Reviews
There are no reviews yet.